Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
Wound healing presents significant clinical challenges, particularly among immunocompromised individuals and patients suffering from chronic systemic conditions such as diabetes. These patient groups are more prone to postoperative complications and frequently experience delayed healing processes. Under normal physiological conditions, wound healing follows a cascade that heavily depends on the formation of granulation tissue, where blood vessels play a crucial role. As the healing tissue matures, the density of these vessels diminishes. However, in diabetic individuals, impaired immune responses and defective neovascularization significantly hinder this process. Interestingly, the oral mucosa demonstrates a unique healing pattern-characterized by a reduced vascular response yet more mature and efficient capillaries. This feature promotes enhanced oxygen delivery to regenerating tissues and contributes to faster healing. A key factor impeding effective wound healing is insufficient tissue oxygenation, often caused by compromised vascular supply. This deficiency adversely affects leukocyte-mediated bacterial clearance and tissue regeneration. Oxygen is vital not only for cellular repair mechanisms but also for its antimicrobial effects, particularly through oxidative microbial destruction.
Studietype
Studietype
Registrering (Faktiske)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Egypt
-
Ismailia, Egypt, Egypt
- Faculty of dentistry Suez canal university
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
-
Age ≥ 18 years (able to sign informed consent).
-
Requires extraction of at least one hopeless tooth meeting one or more of the following:
- Furcation involvement > Class II -Tooth mobility > Grade II
- Probing pocket depth (PPD) > 6 mm
- Alveolar bone loss ≥ 70% of root length
- Persistent radiographic pathology or chronic symptoms (e.g., pain, fistula, infection)
- Non-restorable condition
-
The case can be prepared for implant placement
Exclusion Criteria:
- General contraindications to surgery
- Pregnancy or breastfeeding
- Uncontrolled diabetes
- Current or previous intravenous bisphosphonate therapy
- History of allergic reaction to the applied gel or any of its components
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Study with BlueM gel
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
|
Placebo komparator: Control without BlueM gel
Standard postoperative care without the use of the gel, allowing for natural healing. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Post-operative pain
Tidsramme: 1, 3 and 7 days
|
Post-operative pain levels assessed using the Visual Analog Scale (VAS), where higher scores indicate worse outcomes (more pain). Minimum score = 0 (No pain); Maximum score = 10 (Severe pain that completely prevents daily activities). |
1, 3 and 7 days
|
|
post-operative complications
Tidsramme: 1, 3 and 7 days
|
Measure the incidence of post-operative complications (e.g., dry socket, infection) in both groups. |
1, 3 and 7 days
|
|
Clinical signs of inflammation
Tidsramme: 1, 3 and 7 days
|
Clinical signs of inflammation assessed using an ordinal clinical grading scale for swelling, where higher scores indicate worse outcomes (more severe inflammation). Scale ranges from 1 to 4: 1 = none (no visible swelling), 2 = mild (intraoral swelling in the surgical zone), 3 = moderate (extraoral swelling in the surgical zone), and 4 = severe (extraoral swelling extending beyond the surgical zone and visible hematoma and ecchymosis). |
1, 3 and 7 days
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Bone Density and Vertical Bone Height Assessed by Cone-Beam Computed Tomography (CBCT)
Tidsramme: Immediately and 6 months post-operatively
|
Assessment of bone regeneration promoted by the oxygen-releasing oral gel. Vertical bone height will be measured in millimeters (mm) and bone density will be evaluated using CBCT scans immediately and 6 months post-operatively. |
Immediately and 6 months post-operatively
|
|
Histomorphometric Analysis of Bone Quality Using H&E and Masson's Trichrome Staining
Tidsramme: 6 months post-operatively
|
Assessment of bone quality evaluated by histomorphometric analysis of tissue sections stained with Hematoxylin and Eosin (H&E) and Masson's Trichrome. The measurement quantifies the distribution and number of osteoblasts and osteocytes, as well as the maturation of bone (differentiating between woven and lamellar bone) at 6 months post-operatively. Higher maturation of lamellar bone and balanced cellular distribution indicate better outcomes. |
6 months post-operatively
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: a review of the literature. Dermatol Surg. 2008 Sep;34(9):1159-69. doi: 10.1111/j.1524-4725.2008.34254.x. Epub 2008 May 29.
- Alshehri, F.A., 2023. Role of Topical Oxygen Oral Therapy in Wound Healing of Oral and Periodontal Tissues: A Narrative Review. Pakistan Oral & Dental Journal, 43(3), pp.106-113.
- Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016 Jul;13 Suppl 2(Suppl 2):5-15. doi: 10.1111/iwj.12623.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Faktiske)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
Andre studie-ID-numre
- 2025/1005
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .